Page 44 - Ipid Management News Today

Observational studies suggested patients with COVID-19 taking statins have better outcomes. A new review looks at trials underway assessing lipid-modifying agents to treat or prevent COVID-19.

Greater increases in fasting ghrelin associated with improved metabolic benefits seen with plant-enhanced Mediterranean diet. But one commentator calls the findings simply hypothesis-generating.

Certain blood pressure–lowering agents, especially diuretics, may reduce Alzheimers pathology and other brain disease processes, new research suggests.

Results of a new study provide another reason to get patients to quit the nicotine habit and control other vascular risk factors.

A meta-analysis of seven randomized trials suggests a dose-dependent increased risk of developing atrial fibrillation with marine omega-3 fatty acid supplementation.

Statin use is associated with increased likelihood of diabetes progression, according to a new matched cohort analysis of data from the Department of Veteran Affairs.

Elevated LDL cholesterol is often regarded as a midlife problem, but a new study suggests the damage may be cumulative and begin as early as young adulthood.

The drugs were linked to improvements in Graves orbitopathy, even in people without high LDL-cholesterol; anti-inflammatory effects a possible explanation.

A new study finds inactive lifestyles can lead to more frequent, severe hot flashes, among other negative health effects of not getting enough movement and exercise.

The synthetic triglyceride triheptanoin may restore brain energy and decrease caudate atrophy in Huntington disease -- and improve motor function for up to a year.